-
China has achieved the first flight of green international cargo of biological aviation coal
Time of Update: 2022-12-29
(Photo courtesy of Sinopec)Recently, Chinese mainland first commercial cargo flight using sustainable aviation fuel completed its maiden flight.
(Photo courtesy of Sinopec)Recently, Chinese mainland first commercial cargo flight using sustainable aviation fuel completed its maiden flight.
-
First-in-class immunomodulators are reacquired to fda fast-track for the treatment of scleroderma-related interstitial lung disease
Time of Update: 2022-09-20
S. FDA has granted the company's primary drug candidate, efzofitimod, for the treatment of systemic sclerosis (SSc, also known as scleroderma) related interstitial lung disease (ILD) fast-track qualification, after the FDA granted efzofitimod a fast-track qualification for the treatment of pulmonary sarcoidosis.
-
Polyethylene: Brief Analysis of Import Data in October 2020
Time of Update: 2022-08-25
With the cooling of the northern hemisphere and the approach of autumn and winter, the number of new cases in a single day in many European countries has reached a record high, and the global epidemic has ushered in a second outbreak.
-
The project "Policy Research on Safeguarding my country's Mineral Resources" was launched in Beijing
Time of Update: 2022-04-30
At the same time, the conference held the announcement meeting of the results of the strategic research and consulting project of the Chinese Academy of Engineering, "China's Mining Development Major Policy Research" .
-
Kunbo Medical's lung targeted denervation radiofrequency ablation energy system completes its first clinical application
Time of Update: 2021-11-05
HK), a global leader in precision interventional diagnosis and treatment of lung diseases, completed its lung targeted denervation radiofrequency ablation energy system (below Targeted Lung Denervation) The first clinical application of "TLD") has brought good news to the majority of patients with chronic obstructive pulmonary disease (COPD) .
-
Simcere's clinical trial application for brain edema drug SIM-307 was approved
Time of Update: 2021-07-09
On April 14, Simcere announced that its clinical trial application for the treatment of acute ischemic stroke complicated by cerebral edema, SIM-307, has been approved by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration .
-
The brain health of one-third of people infected with the new crown is affected, and the "Lancet" publication publishes data on 230,000 patients
Time of Update: 2021-04-24
"This is real-world data collected from a large number of patients, which confirms that the diagnosis rate of mental illness after the new crown is high, and it can also cause serious diseases that affect the nervous system (such as stroke and dementia).
-
Studies have shown a lack of pathologists in low- and middle-income countries
Time of Update: 2020-12-17
However, a new study published in , a leading British medical journal, suggests that undiagnosed "hypothetical therapy" may be prevalent in many low- and middle-income countries due to factors such as a severe lack of pathologists.
-
Biological Scaffolds for Heart Valve Tissue Engineering
Time of Update: 2020-12-16
Here, we report a method for efficient removal of cells from ovine heart valve tissue (including cusp, wall, and myocardial cuff) by detergents for the generation of biological valvular scaffolds.
-
Top 25 global biotech companies in 2019: 5 Chinese companies including Hengrui and Wuxi pharmaceutical
Time of Update: 2019-11-06
Compile newborn Recently, foreign biotechnology website Gen released the list of top 25 biotechnology companies of 2019 The list is based on the market value as of October 30, 2019, and the data comes
-
[good medicine record] sprint: another 2 drugs will pass the consistency evaluation; 5 drugs in Kelun weekly report, 4 for injection; and 24 acceptance numbers
Time of Update: 2018-12-21
Up to now, there are 640 acceptance numbers of CDE acceptance consistency evaluation (calculated according to supplementary application, the same below), involving 225 varieties of 238 enterprises, of
-
Looking at the future sales market of Biopharmaceutics from the heavy bomb in the pharmaceutical Hall of fame
Time of Update: 2018-03-15
Source: from March 15, 2018 to the end of 2017, the cumulative sales of six prescription drugs exceeded US $100 billion The top three are Lipitor (Pfizer), sumerial (Albright) and erythropoietin (Amge
-
How can generic drugs seize the market through consistency evaluation
Time of Update: 2017-12-20
Source: the industry reshuffle period brought by the consistency evaluation of e drug manager on December 20, 2017 is coming According to the report of Tianfeng Securities Research Institute, as of De
-
"CHP waters joint open laboratory" unveils the introduction of advanced technology into the composition analysis of traditional Chinese Medicine
Time of Update: 2015-02-06
"CHP waters joint open laboratory" is located in the experimental building of Beijing Zhendong Guangming Pharmaceutical Research Institute, covering an area of about 400 square meters It is understood
-
FDA approval of AstraZeneca orphan drug myalept
Time of Update: 2014-02-26
Source: China Council for the promotion of drugs, AstraZeneca, February 25, 2014, said Tuesday that the U.S Food and drug administration has approved myalept as an adjuvant diet replacement therapy fo
